Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Lonza launches new basal and feed medium to optimize protein production

Lonza launches new basal and feed medium to optimize protein production

Understanding Monoclonal Antibody Unfolding and Aggregation

Understanding Monoclonal Antibody Unfolding and Aggregation

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

BioStreamline project outcomes

BioStreamline project outcomes

BioStreamline: Streamlining the development of next generation biotherapeutics

BioStreamline: Streamlining the development of next generation biotherapeutics

Dupilumab provides clinical benefit to adolescents with moderate-to-severe atopic dermatitis

Dupilumab provides clinical benefit to adolescents with moderate-to-severe atopic dermatitis

Analyses of two clinical trials predict response to asthma drug by COPD patients

Analyses of two clinical trials predict response to asthma drug by COPD patients

Lung cancer may soon be picked up by a blood test

Lung cancer may soon be picked up by a blood test

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Accelerating Nanobody Production using Polyclonal Anti-VHH Antibodies

Accelerating Nanobody Production using Polyclonal Anti-VHH Antibodies

VUMC partners with Batavia to move promising Zika antibody therapy closer to the clinic

VUMC partners with Batavia to move promising Zika antibody therapy closer to the clinic

UC San Diego researchers identify new therapeutic approach to kill cancer cells

UC San Diego researchers identify new therapeutic approach to kill cancer cells

Scientists step closer to an Ebola cure

Scientists step closer to an Ebola cure

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E promotes hepatitis B virus infection

New nanovaccine for deadly skin cancer

New nanovaccine for deadly skin cancer

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement